Literature DB >> 21196624

Drug interaction between rifampicin and sirolimus in transplant patients.

B T Ngo1, M Pascoe, Delawir Khan.   

Abstract

We report two cases of drug interaction between rifampicin and sirolimus in renal trans-plant patients who were diagnosed with tuberculosis after transplantation and induction of immuno-suppressive therapy with sirolimus. The dosage of sirolimus had to be increased, in one case up to six-fold and in the second case up to five-fold, to maintain serum levels after starting the rifampicin. The two patients tolerated the treatment well, with no signs of tuberculosis and good renal function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196624

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  6 in total

Review 1.  Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians.

Authors:  Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid
Journal:  Open Forum Infect Dis       Date:  2022-06-15       Impact factor: 4.423

2.  Large-scale identification and analysis of suppressive drug interactions.

Authors:  Murat Cokol; Zohar B Weinstein; Kaan Yilancioglu; Murat Tasan; Allison Doak; Dilay Cansever; Beste Mutlu; Siyang Li; Raul Rodriguez-Esteban; Murodzhon Akhmedov; Aysegul Guvenek; Melike Cokol; Selim Cetiner; Guri Giaever; Ivan Iossifov; Corey Nislow; Brian Shoichet; Frederick P Roth
Journal:  Chem Biol       Date:  2014-04-03

3.  Tuberculosis before hematopoietic stem cell transplantation in patients with hematologic diseases: report of a single-center experience.

Authors:  K-S Eom; D-G Lee; H-J Lee; S-Y Cho; S-M Choi; J-K Choi; Y-J Kim; S Lee; H-J Kim; S-G Cho; J-W Lee
Journal:  Transpl Infect Dis       Date:  2015-01-12       Impact factor: 2.228

4.  Immune Reconstitution Inflammatory Syndrome Occurring in a Kidney Transplant Patient with Extrapulmonary Tuberculosis.

Authors:  Jose Iglesias; Kandria Jumil Ledesma; Paul J Couto; Jessie Liu
Journal:  Case Rep Transplant       Date:  2017-03-07

5.  Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.

Authors:  Yu-Chen Wang; Noruel Gerard Salvador; Chih-Che Lin; Chao-Chien Wu; Ting-Lung Lin; Wei-Feng Lee; Yi-Chia Chan; Chao-Long Chen; Jeffrey Samuel Co; Domelle Dave Encarnacion
Journal:  Biomed J       Date:  2020-09-04       Impact factor: 7.892

Review 6.  Mycobacterial infections in solid organ transplant recipients.

Authors:  Harun Ur Rashid; Nura Afza Salma Begum; Tasnuva Sarah Kashem
Journal:  Korean J Transplant       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.